Trigemina’s mission is to develop novel, non-opioid, non-sedating, cognition neutral neurological therapies that utilize our novel naso-cerebral delivery systems for relief of chronic migraine and other neuropathic pain.
Member count: 11-50
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Aurus Capi... | aurus.cl |